Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
fexofenadine hydrochloride, Quantity: 180 mg
Dr Reddys Laboratories Australia Pty Ltd
Fexofenadine hydrochloride
Tablet, film coated
Excipient Ingredients: mannitol; magnesium stearate; croscarmellose sodium; powdered cellulose; colloidal anhydrous silica; maize starch; titanium dioxide; hypromellose; allura red AC aluminium lake; iron oxide black; macrogol 400
Oral
50, 60, 70, 80, 90, 100, 10's, 20's and 30's
(S2) Pharmacy Medicine
Seasonal allergic rhinitis, urticaria in adults and children aged 12 years and over.
Visual Identification: Pink coloured, oval shaped, biconvex tablets, debossed with "FXF" on side and "180" on the other.; Container Type: Blister Pack; Container Material: PVC/PE/PVDC/Al; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert
Registered
2011-05-02